{"store":{"baseInfo":{"podcastTitle":"The cart's Podcast","slug":"cart","podcastDescription":"New podcast weblog","podcastLogo":"https://pbcdn1.podbean.com/img/podbean-logo/podbean_59.jpg","podcastShareLogo":null,"podcastUrl":"https://cart.podbean.com","podcastCanSearched":false,"feedUrl":"https://feed.podbean.com/cart/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-m5ikx-15bfb0","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":29,"gmtAdjustment":"GMT+00:00","useDaylightTime":0,"value":0,"text":"(GMT+00:00) Casablanca, Monrovia, Reykjavik","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":null},"podcastDownloads":null,"totalEpisodes":49,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"cart","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-m5ikx-15bfb0-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fcart.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog1425328%26podcastIdTag%3Dm5ikx&dfl=https%3A%2F%2Fcart.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"simple-list"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/YobKMhxYugY","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-3DPN7TMoSJx","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2016 . All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":["https://www.googletagmanager.com/gtag/js?id=G-TP93LLY3WQ","\n window.dataLayer = window.dataLayer || [];\n function gtag(){dataLayer.push(arguments);}\n gtag('js', new Date());\n\n gtag('config', 'G-TP93LLY3WQ',{'allow_enhanced_conversions':true});\n"],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":false,"sectionMaxCount":10,"enableEditorLink":false,"enableEditCookiesNotice":false,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://cart.podbean.com","apiCommonParams":{"t":"6817a517","clientSignature":"0295933504e7be604f9294bb69cb372b","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb10526332-nnzqi","episode":{"id":"pb10526332","idTag":"nnzqi","title":"bispecific antibody","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1425328/Bsab-1200x1200_300x300.jpg","shareLogo":null,"largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1425328/Bsab-1200x1200.jpg","previewContent":null,"content":"

A bispecific antibody is an artificial antibody containing two specific antigen binding sites. It can bridge the target cells and functional molecules and stimulate a directed immune response. Bispecific antibodies can bind to two targeting sites, one is the tumor antigen on the surface of tumor cells, and the other is the antigen on the surface of immune cells.

","publishTimestamp":1543570074,"duration":42,"mediaUrl":"https://mcdn.podbean.com/mf/web/76g5sb/2_bispecific_antibody_Bispecific.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-nnzqi-a09e7c","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-nnzqi-a09e7c","transcriptUrl":null,"permalink":"/e/bispecific-antibody/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PBA09E7CNNZQI","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":0,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-nnzqi-a09e7c","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb10526332","idTag":"nnzqi","title":"bispecific antibody","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1425328/Bsab-1200x1200_300x300.jpg","shareLogo":null,"largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1425328/Bsab-1200x1200.jpg","previewContent":null,"content":"

bispecific antibody

Comments (0)